EOS Inc
EOS, Inc., through its subsidiaries, operates as a distributor of various consumer products in the Asia Pacific. The company offers nutrition supplements; skin care products, such as masks and serums; and water purifiers. It also markets, promotes, and sells ginsenosides supplements under the Bodywafer name. The company was incorporated in 2015 and is based in Taipei, Taiwan.
EOS Inc (EOSS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2024: 0.069x
Based on the latest financial reports, EOS Inc (EOSS) has a cash flow conversion efficiency ratio of 0.069x as of June 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-85.30K) by net assets ($-1.23 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
EOS Inc - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how EOS Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
EOS Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of EOS Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Innorules Co. Ltd.
KO:296640
|
N/A |
|
Aspo PLC
BE:ZYD
|
0.010x |
|
ELETROBRAS N1
BE:L3X
|
0.030x |
|
INFINERA
BE:IX6
|
0.333x |
|
Sazgar Engineering Works Ltd
KAR:SAZEW
|
N/A |
|
DCI O.N.
F:DCIK
|
N/A |
|
Grayscale Litecoin Trust
OTCQX:LTCN
|
N/A |
|
Hyundai Pharmaceutical Co. Ltd.
KQ:004310
|
N/A |
Annual Cash Flow Conversion Efficiency for EOS Inc (2015–2024)
The table below shows the annual cash flow conversion efficiency of EOS Inc from 2015 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-1.06 Million | $-317.32K | 0.298x | 0.00% |
| 2023-12-31 | $-1.06 Million | $-317.32K | 0.298x | +65.96% |
| 2022-12-31 | $-916.29K | $-164.71K | 0.180x | +200.51% |
| 2021-12-31 | $1.09 Million | $-194.25K | -0.179x | +35.08% |
| 2020-12-31 | $1.36 Million | $-373.60K | -0.275x | -388.52% |
| 2019-12-31 | $2.78 Million | $265.18K | 0.095x | +1058.57% |
| 2018-12-31 | $1.64 Million | $13.51K | 0.008x | -66.93% |
| 2017-12-31 | $633.48K | $15.79K | 0.025x | -97.34% |
| 2016-12-31 | $-153.65K | $-144.23K | 0.939x | -55.00% |
| 2015-12-31 | $-95.87K | $-199.99K | 2.086x | -- |